微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 85.6% | 1.27% | 0.93% | 13/157 | 50.55% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 84.81% | 2.43% | -0.08% | 16/157 | 50.61% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 84.88% | 3.22% | 0.11% | 14/157 | -2.2% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 84.79% | 4.02% | 0.3% | 14/157 | 14.83% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 84.53% | 2.58% | 2.09% | 12/157 | 31.96% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 82.8% | 1.46% | 0.7% | 18/157 | 51.88% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 82.23% | 0.66% | 0.88% | 17/157 | 22.51% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 81.51% | 0.23% | -1.08% | 19/157 | 33.12% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 82.4% | 2.42% | 0.98% | 16/157 | 51.76% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 81.61% | -0.11% | -0.1% | 18/157 | 51.61% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 81.69% | -0.36% | 0.45% | 20/157 | 32.47% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 81.32% | -1.41% | 1.08% | 21/157 | 38.42% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 80.45% | -5.51% | -1.53% | 25/157 | 52.97% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 81.7% | -11.63% | -0.34% | 18/157 | 53.83% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 81.98% | 2% | -0.61% | 18/157 | 5.64% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 82.49% | 2% | -3.12% | 20/157 | 20.99% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 85.14% | 2% | -7.9% | 13/157 | 54.39% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 92.45% | 2% | 2% | 8/157 | 55.2% | 首药控股 | 99.93% | 行业排名> |